Company Encyclopedia
View More
name
Global X Funds Global X Aging Population ETF
AGNG.US
News
View More

AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know

Stocks of AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories rose after New York Federal Reserve President John Williams hinted at a potential interest rate cut. This increased the likelihood of a rate cut at the December meeting from 39% to over 73%, boosting market sentiment. AbbVie rose 3.4%, Biogen 4.1%, BioMarin 3.5%, DexCom 3.9%, and Abbott Laboratories 3.6%. The market's reaction highlights the impact of macroeconomic signals on stock prices.

Stock Story·
US
DXCM
+3.10%
US
ABT
+3.34%
US
ABBV
+2.98%
Stock Story·
US
DXCM
+3.10%
US
ABT
+3.34%
US
ABBV
+2.98%

US stocks jump on rate-cut bets but suffer losses for week

U.S. stocks ended higher on Friday, with the Dow and S&P 500 up 1% and Nasdaq just under 1%. However, all three indexes posted weekly losses due to concerns over tech valuations. Nvidia's strong earnings initially boosted its shares, but they fell later. Eli Lilly's shares rose as it became the first drugmaker to reach a $1 trillion market cap. Gap's shares surged over 8% after strong Q3 sales and profit.

marketscreener·
US
LLY
+1.57%
marketscreener·
US
LLY
+1.57%

Health Care Up as Traders Seek Out Evergreen Sector -- Health Care Roundup

Health-care companies rose as traders sought out evergreen sectors in light of recent volatility. Shares of Eli Lilly rose, and the maker of Zepbound and other obesity drugs became the first pharmaceutical company to hit $1 trillion in market capitalization. British drugmaker GSK and U.S. biotechnology company AnaptysBio are suing one another, with dueling allegations about breaching a licensing agreement for cancer treatment Jemperli. Write to Rob Curran at rob.curran@dowjones.com (END) Dow Jones Newswires 11-21-25 1734ET

marketscreener·
US
LLY
+1.57%
UK
GSK
0.00%
marketscreener·
US
LLY
+1.57%
UK
GSK
0.00%

The Score: Nvidia, Constellation, Eli Lilly, Gap and More Stocks That Defined the Week

The Score is a weekly review of the biggest stock moves and the news that drove them.

MSN·
US
CEG
-2.22%
US
NVDA
-0.97%
US
LLY
+1.57%
MSN·
US
CEG
-2.22%
US
NVDA
-0.97%
US
LLY
+1.57%

TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors

TherapeuticsMD Inc. (TXMD) stock fell 7.29% to $1.78 on Friday, underperforming compared to competitors like AbbVie Inc. (ABBV), which rose 2.98%. The NASDAQ Composite Index and Dow Jones Industrial Average both saw gains. TXMD's trading volume was significantly below its 50-day average, and the stock is 27.05% short of its 52-week high.

Dow Jones·
US
ABBV
+2.98%
Dow Jones·
US
ABBV
+2.98%